The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity
Pamela Chan, Carla V. Rothlin(Yale University), Sourav Ghosh(Yale University), Eugenio Antonio Carrera Silva(Academia Nacional de Medicina), De’Broski R. Herbert(Tulane University), Liming Hao(China State Shipbuilding (China)), Jorge Correale(Consejo Nacional de Investigaciones Científicas y Técnicas), Leonel Joannas(Yale University), Jason S. Weinstein(Rutgers, The State University of New Jersey), Richard A. Flavell(Yale University), Silvia Repetto(Universidad de Buenos Aires), Esteban G. Burchard(University of California, San Francisco), Scott Huntsman(University of California, San Francisco), Dimitri de Kouchkovsky(Yale University), Celeste Eng(University of California, San Francisco), Paula Licona-Limón(Yale University), Donglei Hu(University of California, San Francisco), Dara G. Torgerson(University of California, San Francisco), Joseph Craft(Yale University)
Cited by 93
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
|Nature Medicine|2000|2.1k
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
|Proceedings of the National Academy of Sciences|2014|2.1k